Syndax Pharmaceuticals (SNDX) EPS (Basic) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly EPS (Basic) of -$0.48 for Q1 2026, up 51.0% year-over-year from -$0.32 in Q1 2025, and down 22.43% quarter-over-quarter from -$0.39 in Q4 2025.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) EPS (Basic) (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.48 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 51.0% year-over-year to -$0.48; the TTM figure through Mar 2026 stood at -$2.41 (up 38.56% YoY), while the FY2025 annual figure was -$3.55, up 46.93% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.48, down from -$0.39 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.39 in Q4 2025, with the low at -$1.1 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.73 (2023), against an average of -$0.75.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) tumbled 131.05% in 2022, then soared 64.27% in 2025.
- Syndax Pharmaceuticals' EPS (Basic) stood at -$0.57 in 2022, then slumped by 42.83% to -$0.81 in 2023, then slumped by 35.36% to -$1.1 in 2024, then jumped by 64.27% to -$0.39 in 2025, then fell by 22.43% to -$0.48 in 2026.
- Business Quant data shows SNDX's EPS (Basic) at -$0.48 in Q1 2026, -$0.39 in Q4 2025, and -$0.7 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Syndax Pharmaceuticals | 1.85 Bn | 1.30 Bn | 60.67 Mn | -0.41 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.41 |
| Mar 31, 2026 | -0.39 |
| Dec 31, 2025 | -0.67 |
| Sep 30, 2025 | -0.60 |
| Jun 30, 2025 | -0.73 |
| Mar 31, 2025 | -0.97 |
| Dec 31, 2024 | -1.04 |
| Sep 30, 2024 | -0.99 |
| Jun 30, 2024 | -0.87 |
| Mar 31, 2024 | -0.95 |
| Dec 31, 2023 | -1.03 |
| Sep 30, 2023 | -0.73 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.66 |
| Dec 31, 2022 | -0.64 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 1.84 |
| Sep 30, 2021 | -0.40 |